Beranda › Kanker Kepala dan Leher › Illinois › Chicago
Uji klinis Kanker Kepala dan Leher di Chicago, IL
10 studi untuk Kanker Kepala dan Leher mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Menerima pesertaFase 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- University of Illinois Cancer Center, Chicago
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
Menerima pesertaFase 2
- The University of Chicago, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Menerima pesertaFase 1/2
- University of Chicago, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
Menerima pesertaFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Menerima pesertaFase 1
- The University of Chicago, Chicago
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
Menerima pesertaFase 2
- The University of Chicago, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
Menerima pesertaFase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chicago
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Menerima pesertaFase 1/2
- University of Illinois at Chicago, Chicago
Uji klinis Kanker Kepala dan Leher di kota lain
- Houston, TX30 studi
- Boston, MA22 studi
- New York City, NY21 studi
- Nashville, TN21 studi
- St. Louis, MO15 studi
- Dallas, TX12 studi
- Pittsburgh, PA11 studi
- Los Angeles, CA10 studi
- San Antonio, TX10 studi
- Baltimore, MD10 studi
- Washington, DC10 studi
- Durham, NC10 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara59 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Kanker Paru41 studi
- Obesitas41 studi
- Kanker Ovarium36 studi
- Kanker Kolorektal34 studi
- Stroke34 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan29 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.